Medication can be one of the most important parts of opioid addiction treatment. But naltrexone, buprenorphine and methadone work in very different ways. Understanding those differences can help you have a better conversation with your doctor about which treatment may fit your circumstances.
There is no single opioid addiction medication that is automatically right for everyone.
People searching for opioid addiction treatment near Miami may encounter three major medication options: methadone, buprenorphine and naltrexone.
All three are established treatments for opioid use disorder, but they differ in how they affect opioid receptors, how treatment begins, how they are administered and what the patient experiences while taking them.
The right decision may depend on current opioid use, previous treatment, withdrawal history, personal preference, medical circumstances, access to treatment and whether the person can complete the opioid-free preparation required before starting naltrexone.
This guide explains the differences so Miami and South Florida residents can better understand their options.
Naltrexone, Buprenorphine and Methadone: What’s the Difference?
These medications all treat opioid use disorder, but they do not work in the same way.
Methadone
Methadone is a long-acting full opioid agonist. It activates opioid receptors in a controlled, medically supervised way.
When appropriately prescribed, methadone can reduce withdrawal symptoms, cravings and illicit opioid use without producing the repeated cycle of intoxication and withdrawal associated with uncontrolled heroin or fentanyl use.
In the United States, methadone used to treat opioid use disorder is generally dispensed through certified opioid treatment programs.
Buprenorphine
Buprenorphine is a partial opioid agonist. It activates opioid receptors, but its effects reach a ceiling at higher doses.
It can reduce opioid withdrawal and cravings and is available in several formulations, including sublingual products and long-acting injections.
Buprenorphine can be prescribed by appropriately authorized healthcare professionals in ordinary medical settings, making it more accessible than methadone for many U.S. patients.
Naltrexone
Naltrexone works differently from both methadone and buprenorphine.
It is an opioid antagonist. Rather than activating opioid receptors, it occupies and blocks them.
Naltrexone does not produce an opioid high and does not create opioid-type physical dependence.
However, the patient must first complete an appropriate opioid-free period before naltrexone can be started safely.
How the Three Opioid Treatments Compare
The answer depends on your current opioid use, medication, previous treatment and recovery goals. Speak with DeBinge about whether an opioid-antagonist approach may be appropriate for your circumstances.
Book Your Free Consultation →Methadone: Stabilizing Opioid Dependence
Methadone has been used to treat opioid use disorder for decades.
Because it is a full opioid agonist, methadone activates the same receptor system as heroin, fentanyl and prescription opioids, but treatment is carefully controlled and medically supervised.
An appropriate maintenance dose can reduce withdrawal and cravings and help prevent repeated cycles of illicit opioid use.
Why Some Patients Choose Methadone
It can be particularly useful for people with substantial opioid dependence or those who have not done well with other treatment approaches.
Patients do not need to complete a prolonged opioid-free period before beginning treatment.
What to Consider
Methadone is itself an opioid and can produce physical dependence.
Treatment for opioid use disorder in the United States is generally provided through federally regulated opioid treatment programs, particularly during the earlier stages of care.
Buprenorphine: Reducing Withdrawal and Cravings
Buprenorphine is also an opioid medication, but it is a partial rather than a full opioid agonist.
Its pharmacology allows it to suppress withdrawal and cravings while producing a ceiling effect on some opioid effects.
It can be prescribed in medical settings outside traditional opioid treatment programs and is available in daily and longer-acting formulations.
Naltrexone: A Different Approach to Opioid Recovery
Naltrexone takes a fundamentally different approach.
It does not activate opioid receptors. Instead, it binds to them and prevents or substantially reduces the effects of opioids while sufficient receptor blockade is present.
This makes naltrexone an option for people who prefer an opioid-free antagonist treatment after completing the necessary transition away from opioids.
Because it does not act as an opioid agonist, naltrexone does not produce an opioid high or opioid-type physical dependence.
Potential Advantages
For a medically suitable patient who has successfully completed opioid withdrawal, naltrexone can provide ongoing opioid receptor blockade.
Longer-acting formulations can also reduce reliance on remembering a medication every day.
The Main Challenge
A person must first be sufficiently free from opioids.
This transition period can make initiating naltrexone more difficult for some patients compared with methadone or buprenorphine.
Naltrexone Cannot Be Started While You Are Still Opioid-Dependent
This is one of the most important things to understand when comparing these medications.
Giving naltrexone to someone who still has significant opioid dependence can rapidly displace opioids from their receptors and cause severe precipitated withdrawal.
The necessary opioid-free period depends on the drug being used and individual clinical circumstances.
Heroin, fentanyl, prescription opioids, methadone and buprenorphine can require different transition plans.
Is Naltrexone Better Than Buprenorphine or Methadone?
There is no responsible medical answer that says one of these medications is universally best for every patient.
Methadone and buprenorphine can be particularly valuable because patients can begin treatment without first completing the opioid-free transition required for naltrexone.
Naltrexone may appeal to patients who want an antagonist approach that does not involve ongoing opioid receptor activation and who can successfully complete the necessary preparation.
Treatment selection should therefore be based on individual circumstances rather than on marketing claims about one medication being superior to all others.
Current Opioid Use
Someone actively dependent on fentanyl, heroin, methadone or another opioid may need a very different pathway from someone who has already completed withdrawal.
Previous Treatment
Past experiences with buprenorphine, methadone, naltrexone, detoxification and relapse can help inform the next decision.
Ability to Complete Withdrawal
Naltrexone requires an opioid-free transition. This may be achievable for one patient and a major barrier for another.
Treatment Preference
Some patients prefer opioid agonist treatment. Others specifically want an opioid-antagonist approach once medically ready.
Access and Continued Care
The best medication is only useful when the patient can realistically start it, continue it and receive appropriate medical and recovery support.
Opioid Treatment Should Always Include Overdose Planning
Opioid use disorder carries a serious overdose risk, particularly in an illicit drug supply where fentanyl may be present.
Treatment can reduce risk, but patients and families should still understand overdose prevention.
After a period without opioids, tolerance can fall. Returning to a dose previously tolerated can therefore become more dangerous.
Patients receiving naltrexone should never attempt to overcome opioid receptor blockade by taking larger quantities of opioids.
What Opioid Treatment Options Are Available to Miami Residents?
Miami residents do not need to use the same treatment pathway simply because they live in the same city.
Treatment in Miami
Local treatment may provide access to methadone programs, buprenorphine-prescribing clinicians, extended-release injectable naltrexone, counseling, mental-health services and overdose-prevention resources.
Remaining local can be particularly important when someone requires frequent medication management or close medical support.
Treatment in The Bahamas
For a medically suitable patient who wants an antagonist approach and can complete the required opioid-free preparation, DeBinge offers assessment for long-acting naltrexone treatment in Nassau.
Treatment abroad should be considered only after clinical assessment rather than as a substitute for urgent local care.
The DeBinge Approach to Opioid Recovery
DeBinge is not an opioid treatment center located in Miami.
DeBinge is located in Sandyport, Nassau, The Bahamas and works with patients who may travel from Miami, South Florida and elsewhere in the United States.
DeBinge focuses on an opioid-antagonist pathway using long-acting naltrexone for medically appropriate patients.
Treatment is not simply an implant procedure. The wider program includes assessment, clinical preparation, medical care and continued counseling.
Free Initial Consultation
Discuss the opioids you are currently taking, previous treatment, medications and what you want to achieve from recovery.
Medical Assessment
The team reviews whether a naltrexone-based pathway is medically suitable and what preparation would be necessary.
Opioid-Free Preparation
Appropriate preparation must be completed before naltrexone treatment. The timing depends on the opioids or opioid medications involved.
Long-Acting Naltrexone
Once medically cleared, an appropriate patient may receive sustained-release naltrexone as one component of the broader recovery plan.
One Year of Professional Counseling
Recovery continues after the clinical treatment stage with counseling focused on triggers, behavior, relationships, routines and long-term recovery.
What Should Americans Know About Naltrexone Implants?
Naltrexone itself is an established medication for opioid use disorder.
In the United States, the FDA-approved long-acting naltrexone formulation for opioid use disorder is extended-release injectable naltrexone.
A sustained-release naltrexone implant is a different formulation and is not FDA-approved for clinical use in the United States.
A U.S. patient considering implant treatment abroad should therefore understand the exact formulation, available clinical evidence, expected release profile, possible risks, alternatives and follow-up plan.
Why Might Someone Consider Long-Acting Naltrexone?
Oral naltrexone requires a person to make the decision to take a tablet repeatedly.
For some patients, adherence can become difficult, particularly during periods of craving or emotional stress.
A sustained-release formulation reduces reliance on remembering or choosing a tablet every day.
That does not make long-acting naltrexone a cure for opioid addiction, and it does not remove the need for counseling, behavioral change or overdose-prevention planning.
Its potential value is providing sustained medication support while those other parts of recovery continue.
Learn more about long-acting naltrexone →Questions to Ask Your Opioid Treatment Provider
- Why are you recommending this medication rather than the other FDA-approved opioid treatments?
- Can I begin treatment while I am still physically dependent on opioids?
- What withdrawal or medication transition will be required?
- How long is the medication expected to remain active?
- What happens if I experience strong cravings after treatment begins?
- What counseling or behavioral treatment is included?
- How will overdose risk and naloxone access be addressed?
- What support continues after the initial medical treatment?
How a Miami Resident Can Start With DeBinge
Book a Free Consultation
Tell the team what opioids or opioid medications you are currently taking, your previous treatment and your recovery goals.
Book your consultation →Review Your Treatment Options
Understand whether a naltrexone pathway fits your circumstances and whether another established OUD medication may be more appropriate.
Complete Clinical Preparation
If naltrexone is selected, the required opioid-free transition and medical preparation must take place before treatment.
Travel When Medically Appropriate
Treatment in Nassau should be arranged after the clinical pathway has been established rather than booking travel before assessment.
Continue Recovery After Returning Home
Medication is one part of treatment. Continued counseling and recovery planning help address triggers and life after the patient returns to Miami or elsewhere in the United States.
If you live in Miami or elsewhere in South Florida, speak with DeBinge about your opioid use, current medications, previous treatment and whether a long-acting naltrexone pathway may be appropriate for you.
Opioid Addiction Treatment Near Miami
What are the main medications for opioid addiction?
The three FDA-approved medications for opioid use disorder are methadone, buprenorphine and naltrexone. They work differently, and treatment should be chosen according to the patient’s clinical circumstances, preferences and ability to access and continue care.
What is the difference between methadone and buprenorphine?
Methadone is a full opioid agonist, while buprenorphine is a partial opioid agonist. Both can reduce withdrawal and cravings, but they differ in pharmacology, access, dosing and how treatment is managed.
How is naltrexone different?
Naltrexone is an opioid antagonist. It does not activate opioid receptors. Instead, it blocks them and can substantially reduce or prevent opioid effects while adequate receptor blockade is present.
Do I need to detox before starting naltrexone?
A patient must be appropriately opioid-free before starting naltrexone. Starting it while someone remains physically dependent on opioids can cause severe precipitated withdrawal. The required transition should be determined by a clinician.
Is naltrexone better than methadone or buprenorphine?
Not for every patient. All three are established medications for opioid use disorder. The most appropriate option depends on current opioid use, previous treatment, medical circumstances, treatment preferences and the ability to begin and remain on the selected medication.
Can I switch from methadone or buprenorphine to naltrexone?
Transitioning from an opioid agonist medication to naltrexone requires careful clinical planning because naltrexone cannot be started while significant opioid dependence remains. The timing and transition plan should be determined by qualified clinicians.
Does naltrexone guarantee that I cannot relapse?
No. Naltrexone can provide opioid receptor blockade and support relapse prevention, but no medication guarantees that a person will never return to opioid use. Counseling and continued recovery work remain important.
Is DeBinge an opioid treatment center in Miami?
No. DeBinge is located in Sandyport, Nassau, The Bahamas. Patients from Miami can begin with a consultation and medical assessment before deciding whether treatment abroad is appropriate.
Should I keep naloxone even if I am receiving treatment?
Opioid overdose prevention remains important during recovery. Discuss access to naloxone with your healthcare provider and make sure family members or close contacts understand how it is used.
Clinical Information & Further Reading
FDA — Medications for Opioid Use Disorder:
FDA — Information About Medications for Opioid Use Disorder
SAMHSA — Medications for Opioid Use Disorder:
SAMHSA — Opioid Use Disorder Treatment Options
DeBinge — Opioid & Heroin Addiction Treatment:
debinge.com/opioid-heroin-addction/
DeBinge — Naltrexone Implant Clinic:
debinge.com/naltexone-implant-clinic/
Emergency: If someone is unresponsive, breathing very slowly or not breathing, has blue or gray lips or fingertips, or you suspect an opioid overdose, call 911 immediately and administer naloxone if available.